| Mrs Pramila N Jaladanki, CRNP | |
|
5755 Cedar Ln, Columbia, MD 21044-2912 | |
| (410) 740-7890 | |
| Not Available |
| Full Name | Mrs Pramila N Jaladanki |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 5755 Cedar Ln, Columbia, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053834069 | NPI | - | NPPES |
| R163269 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | R163269 (Maryland) | Secondary |
| 208M00000X | Hospitalist | R163269 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Hospital Center | Randallstown, MD | Hospital |
| Adventist Healthcare White Oak Medical Center | Silver spring, MD | Hospital |
| University Of Md Baltimore Washington Medical Center | Glen burnie, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Usacs Integrated Acute Care Services Of Maryland Llc | 4486900172 | 218 |
| Mep Observation Services Llc | 2365611845 | 36 |
| Mdics At Bwmc Llc | 7315106184 | 63 |
News Archive
A self-administered test to screen for early dementia could help speed the diagnosis and subsequent treatment of memory disorders, including Alzheimer's disease. It could also provide health care providers and caregivers an earlier indication of life-changing events that could lie ahead.
The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $195,000 to ALS Biopharma, LLC to develop therapeutics targeted at clearing toxic proteins implicated in Alzheimer's disease.
A research review carried out by the HRB Centre for Primary Care Research, based in the Royal College of Surgeons in Ireland (RCSI) and published in this month's edition of the British Medical Journal (BMJ) has focused on how we can improve care and outcomes for patients with multimorbidity (co-existence of two or more long-terms health conditions in an individual).
Persistent genital arousal disorder-which is almost exclusively experienced by females and characterized by spontaneous and unwanted sexual arousal unrelated to desire-can compromise individuals' mental health and well-being and severely damage relationships with partners.
› Verified 7 days ago
| Entity Name | Emergency Medicine Associates Pa Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134117393 PECOS PAC ID: 8022914522 Enrollment ID: O20070919000389 |
News Archive
A self-administered test to screen for early dementia could help speed the diagnosis and subsequent treatment of memory disorders, including Alzheimer's disease. It could also provide health care providers and caregivers an earlier indication of life-changing events that could lie ahead.
The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $195,000 to ALS Biopharma, LLC to develop therapeutics targeted at clearing toxic proteins implicated in Alzheimer's disease.
A research review carried out by the HRB Centre for Primary Care Research, based in the Royal College of Surgeons in Ireland (RCSI) and published in this month's edition of the British Medical Journal (BMJ) has focused on how we can improve care and outcomes for patients with multimorbidity (co-existence of two or more long-terms health conditions in an individual).
Persistent genital arousal disorder-which is almost exclusively experienced by females and characterized by spontaneous and unwanted sexual arousal unrelated to desire-can compromise individuals' mental health and well-being and severely damage relationships with partners.
› Verified 7 days ago
| Entity Name | M Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780056168 PECOS PAC ID: 7719278597 Enrollment ID: O20160627000350 |
News Archive
A self-administered test to screen for early dementia could help speed the diagnosis and subsequent treatment of memory disorders, including Alzheimer's disease. It could also provide health care providers and caregivers an earlier indication of life-changing events that could lie ahead.
The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $195,000 to ALS Biopharma, LLC to develop therapeutics targeted at clearing toxic proteins implicated in Alzheimer's disease.
A research review carried out by the HRB Centre for Primary Care Research, based in the Royal College of Surgeons in Ireland (RCSI) and published in this month's edition of the British Medical Journal (BMJ) has focused on how we can improve care and outcomes for patients with multimorbidity (co-existence of two or more long-terms health conditions in an individual).
Persistent genital arousal disorder-which is almost exclusively experienced by females and characterized by spontaneous and unwanted sexual arousal unrelated to desire-can compromise individuals' mental health and well-being and severely damage relationships with partners.
› Verified 7 days ago
| Entity Name | Usacs Integrated Acute Care Services Of Maryland Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922598929 PECOS PAC ID: 4486900172 Enrollment ID: O20190604001354 |
News Archive
A self-administered test to screen for early dementia could help speed the diagnosis and subsequent treatment of memory disorders, including Alzheimer's disease. It could also provide health care providers and caregivers an earlier indication of life-changing events that could lie ahead.
The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $195,000 to ALS Biopharma, LLC to develop therapeutics targeted at clearing toxic proteins implicated in Alzheimer's disease.
A research review carried out by the HRB Centre for Primary Care Research, based in the Royal College of Surgeons in Ireland (RCSI) and published in this month's edition of the British Medical Journal (BMJ) has focused on how we can improve care and outcomes for patients with multimorbidity (co-existence of two or more long-terms health conditions in an individual).
Persistent genital arousal disorder-which is almost exclusively experienced by females and characterized by spontaneous and unwanted sexual arousal unrelated to desire-can compromise individuals' mental health and well-being and severely damage relationships with partners.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Pramila N Jaladanki, CRNP 5755 Cedar Ln, Columbia, MD 21044-2912 Ph: (410) 740-7890 | Mrs Pramila N Jaladanki, CRNP 5755 Cedar Ln, Columbia, MD 21044-2912 Ph: (410) 740-7890 |
News Archive
A self-administered test to screen for early dementia could help speed the diagnosis and subsequent treatment of memory disorders, including Alzheimer's disease. It could also provide health care providers and caregivers an earlier indication of life-changing events that could lie ahead.
The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $195,000 to ALS Biopharma, LLC to develop therapeutics targeted at clearing toxic proteins implicated in Alzheimer's disease.
A research review carried out by the HRB Centre for Primary Care Research, based in the Royal College of Surgeons in Ireland (RCSI) and published in this month's edition of the British Medical Journal (BMJ) has focused on how we can improve care and outcomes for patients with multimorbidity (co-existence of two or more long-terms health conditions in an individual).
Persistent genital arousal disorder-which is almost exclusively experienced by females and characterized by spontaneous and unwanted sexual arousal unrelated to desire-can compromise individuals' mental health and well-being and severely damage relationships with partners.
› Verified 7 days ago